Antigens on melanoma cells detected by leukocyte dependent antibody assays of human melanoma antisera
- PMID: 62719
- DOI: 10.1002/ijc.2910180504
Antigens on melanoma cells detected by leukocyte dependent antibody assays of human melanoma antisera
Abstract
Antibody-dependent cell-mediated cytotoxic assays have been used to examine antigens on human melanoma cells obtained either directly from patients or from long-term melanoma cell lines. A panel of melanoma antisera was selected from human subjects which could be shown not to have significant reactivity to histocompatibility antigens. With these antisera extensive cross-reactions between melanoma cells were found. However, the cross-reactivity was incomplete and the pattern of reactivity was different for each antiserum tested. These results were not consistent with a common melanoma antigen on human melanoma cells but rather indicated heterogeneity of melanoma antigens and multiple antibody specificities in the sera tested. This appeared to be confirmed by extensive cross-absorption studies which indicated limited cross-reactivity of antigens on melanoma cells from either long-term or short-term cultures. Several changes in the antigenic profile of melanoma cells in vitro from both long-term and short-term cultures were documented which resulted from contamination of the melanoma cell lines with non-melanoma cells and fibroblasts. Melanoma antisera may therefore be useful to mintor changes in long-term cultures which would otherwise give spurious results in in vitro tests. These results appear to have considerable significance for understanding tumour/host relationships and for the establishment of rational immunotherapeutic procedures and diagnostic tests in melanoma.
Similar articles
-
Human melanoma and leukemia associated antigens difined by nonhuman primate antisera.Fed Proc. 1975 Jul;34(8):1642-6. Fed Proc. 1975. PMID: 805717 Review.
-
Production of antisera with specificity for malignant melanoma and human fetal skin.Cancer Res. 1976 Feb;36(2 Pt 1):458-66. Cancer Res. 1976. PMID: 56991
-
Constancy of cross reactivity patterns during the anti-HL-A response.Transplantation. 1975 Dec;20(6):503-11. doi: 10.1097/00007890-197512000-00010. Transplantation. 1975. PMID: 1209727
-
Surface antigens on human melanoma cells studied with heterologous antisera.Br J Cancer. 1980 Sep;42(3):399-407. doi: 10.1038/bjc.1980.251. Br J Cancer. 1980. PMID: 6158972 Free PMC article.
-
Studies of humoral and cell-mediated immunity in human melanoma.Yale J Biol Med. 1973 Dec;46(5):681-92. Yale J Biol Med. 1973. PMID: 4130586 Free PMC article. Review. No abstract available.
Cited by
-
[Limits and possibilities of neoplasm immunotherapy].Naturwissenschaften. 1978 Apr;65(4):180-7. doi: 10.1007/BF00450586. Naturwissenschaften. 1978. PMID: 78457 German.
-
Humoral and cellular immune reactions against tumor cells in patients with urinary bladder carcinoma. Correlation between direct and antibody-dependent cell-mediated cytotoxicity.Cancer Immunol Immunother. 1983;16(1):23-9. doi: 10.1007/BF00199901. Cancer Immunol Immunother. 1983. PMID: 6556949 Free PMC article.
-
Human E-rosette forming lymphocytes exhibiting antibody-dependent cytotoxic activity.Blut. 1977 May;34(5):388-92. doi: 10.1007/BF00996081. Blut. 1977. PMID: 301413 No abstract available.
-
Characterization of an inhibitor of cell division released in tumour cell cultures.Clin Exp Immunol. 1980 Sep;41(3):487-96. Clin Exp Immunol. 1980. PMID: 7438562 Free PMC article.
-
Phase II study of vaccinia melanoma cell lysates (VMCL) as adjuvant to surgical treatment of stage II melanoma. II. Effects on cell mediated cytotoxicity and leucocyte dependent antibody activity: immunological effects of VMCL in melanoma patients.Cancer Immunol Immunother. 1986;22(3):221-31. doi: 10.1007/BF00200037. Cancer Immunol Immunother. 1986. PMID: 3460702 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources